The eazyplex® SARS-CoV-2 is a rapid assay that accurately identifies samples with high viral loads. It may be useful for near-patient testing outside of a molecular diagnostic laboratory.
National Institute for Health Research Biomedical Research Centre and AstraZeneca.
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
Cases of unusual thrombosis and thrombocytopenia after administration of the ChAdOx1 nCoV-19 vaccine (AstraZeneca) have been reported. The term vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) was coined to reflect this new...
Controversy continues about the significance of fomite transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent papers continue to advocate concern. However, designs of studies showing virus survival on surfaces...
In severe/critical COVID-19 patients, myoglobin and troponin were predictors of mortality and the probability of conversion to critical illness, and myoglobin may be superior to troponin for predictive value.
Non-steroidal anti-inflammatory drug use in COVID-19
Coronavirus disease 2019 (COVID-19), the illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a devastating effect on the world's population resulting in more than 6 million deaths worldwide and emerging...
Clinical manifestations are diverse, fluctuating and variable, although fatigue and neurocognitive complaints predominate. There is no defined consensus on post-COVID-19 syndrome and its diagnostic criteria have not been subjected to adequate psychometric evaluation.
The Impact of the Covid-19 Pandemic on Global Population Ageing
Try “site:ncbi.nlm.nih.gov” on: Marginalia · Mojeek · Wiby · DuckDuckGo · Bing · Google · Wikipedia · Internet Archive